Keyphrases
High Risk
100%
TP53 mutation
100%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
100%
Diagnostic Marker
100%
Clinical Significance
33%
Mutation Carriers
33%
Leukemia Patients
33%
Germ Cells
33%
Poor Prognosis
33%
Acute Lymphoblastic Leukemia
33%
Childhood Acute Lymphoblastic Leukemia
33%
Working Diagnosis
33%
Overall Survival
33%
Single-base Substitution
33%
Exon 7
33%
Childhood Malignancy
33%
B-lineage
33%
Risk Prognosis
33%
Relapse-free Survival
33%
T-lineage
33%
Medicine and Dentistry
Protein P53
100%
Acute Lymphoblastic Leukemia
100%
Intron
100%
Diagnostic Marker
100%
Base
50%
Childhood Cancer
25%
Exon
25%
Overall Survival
25%
Recurrence Free Survival
25%
Germ Line
25%
Leukemia in Children
25%
Germ Cell
25%
Biochemistry, Genetics and Molecular Biology
Intron
100%
P53
100%
Exon
50%
Germ Cell
50%
T Cell
50%
Nucleic Acid Base Substitution
50%
Overall Survival
50%
Recurrence Free Survival
50%
Immunology and Microbiology
Intron
100%
P53
100%
Lineages
100%
T Cell
25%
Exon
25%
Germ Line
25%
Recurrence Free Survival
25%
Nucleic Acid Base Substitution
25%
Overall Survival
25%
Germ Cell
25%
Neuroscience
P53
100%
Intron
100%
T Cell
50%
Germ Cell
50%
Exon
50%
Pharmacology, Toxicology and Pharmaceutical Science
Protein P53
100%
Acute Lymphoblastic Leukemia
100%
Base
50%
Childhood Cancer
25%
Overall Survival
25%
Recurrence Free Survival
25%